Innate immunity, insulin resistance and type 2 diabetes

Diabetologia

Volumn 55, Issue 2, 2012, Pages 273-278

  Fernandez Real J M ^a,b,d   Pickup, J C ^c  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c GUY S HOSPITAL   (United Kingdom)

^d GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

Author keywords

Clinical studies; Cytokines; Glucose tolerance; Inflammation; Innate immunity; Insulin resistance; Insulin sensitivity; Macrophages; Pathophysiology; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; INSULIN; INTERLEUKIN 6; METFORMIN; MICRORNA; PROTEIN P53; TUMOR NECROSIS FACTOR;

ACUTE PHASE RESPONSE; ADIPOSE TISSUE; AGING; ARTICLE; CYTOKINE PRODUCTION; DIET THERAPY; DISEASE ACTIVITY; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INNATE IMMUNITY; INSULIN RELEASE; INSULIN RESISTANCE; INTERMETHOD COMPARISON; KINESIOTHERAPY; MACROPHAGE FUNCTION; MICROFLORA; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION;

ACUTE-PHASE PROTEINS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; MALE;

EID: 84856750690     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2387-y     Document Type: Article

References (18)

1. Yki-Järvinen H, Williams G (1997) Insulin resistance in non-insulin-dependent diabetes. In: Pickup JC, Williams G (eds) Textbook of diabetes, 2nd edn. Blackwell Science, Oxford, pp 20.1-20.14
2. JC Pickup MB Mattock GD Chusney D Burt 1997 NIDDM as a disease of the innate immune system: association of acute phase reactants and interleukin-6 with metabolic syndrome X Diabetologia 40 1286 1292 9389420 10.1007/ s001250050822 1:CAS:528:DyaK2sXntFynsbc%3D (Pubitemid 27469668)
3. JM Fernández-Real W Ricart 1999 Insulin resistance and inflammation in an evolutionary perspective. The contribution of cytokine genotype/phenotype to thriftiness Diabetologia 42 1367 1374 10550422 10.1007/s001250051451 (Pubitemid 29500975)
4. M Stumvoll PA Tataranni N Stefan B Vozarova C Bogardus 2003 Glucose allostasis Diabetes 52 903 909 12663459 10.2337/diabetes.52.4.903 1:CAS:528:DC%2BD3sXislOnsr0%3D (Pubitemid 36384258)
5. A Bonnefond P Froguel M Vaxillaire 2010 The emerging genetics of type 2 diabetes Trends Mol Med 16 407 416 20728409 10.1016/j.molmed.2010.06.004 1:CAS:528:DC%2BC3cXhtFajs7zK
6. C Huth IM Held C Vollmeert, et al. 2006 IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies Diabetes 55 2915 2921 17003362 10.2337/db06-0600 1:CAS:528: DC%2BD28XhtVGls77I (Pubitemid 44923696)
7. JM Fernández-Real JC Pickup 2008 Innate immunity, insulin resistance and type 2 diabetes Trends Endocrinol Metab 19 10 16 18082417 10.1016/j.tem.2007.10.004
8. V Emilsson G Thorleirsson B Zhang, et al. 2008 Genetics of gene expression and its effect on disease Nature 452 423 428 18344981 10.1038/nature06758 1:CAS:528:DC%2BD1cXjslCnu74%3D (Pubitemid 351450845)
9. JM Olefsky CK Glass 2010 Macrophages, inflammation, and insulin resistance Annu Rev Physiol 72 219 246 20148674 10.1146/annurev-physiol-021909- 135846 1:CAS:528:DC%2BC3cXktFKkt70%3D
10. JM Fernández-Real S Pérez del Pulgar E Luche, et al. 2011 CD14 modulates inflammation-driven insulin resistance Diabetes 60 2179 2186 21700881 10.2337/db10-1210
11. FJ Ortega, et al. 2010 MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation PLoS One 5 e9022 20126310 10.1371/journal.pone.0009022
12. T Minamino M Orimo I Shimizu, et al. 2009 A crucial role for adipose tissue p53 in the regulation of insulin resistance Nat Med 15 1082 1087 19718037 10.1038/nm.2014 1:CAS:528:DC%2BD1MXhtVKhs7vE
13. JM Moreno-Navarrete F Ortega M Sabater W Ricart JM Fernández-Real 2010 Telomere length of subcutaneous adipose tissue cells is shorter in obese and formerly obese subjects Int J Obes (Lond) 34 1345 1348 10.1038/ijo.2010.49 1:CAS:528:DC%2BC3cXhtVSmsLrF
14. A Reyes M Haynes N Hanson, et al. 2010 Viruses in the faecal microbiota of monozygotic twins and their mothers Nature 466 334 338 20631792 10.1038/nature09199 1:CAS:528:DC%2BC3cXosl2rs7c%3D
15. PJ Turnbaugh RE Ley MA Mahowald V Magrini ER Mardis JI Gordon 2006 An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 1027 1031 17183312 10.1038/nature05414 (Pubitemid 46018515)
16. J Amar C Chabo A Waget, et al. 2011 Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment EMBO Mol Med 3 559 572 21735552 10.1002/emmm.201100159 1:CAS:528:DC%2BC3MXhtF2hs7nN
17. R Krishnapuram EJ Dhurandhar O Dubuisson, et al. 2011 Template to improve glycemic control without reducing adiposity or dietary fat Am J Physiol Endocrinol Metab 300 E779 E789 21266671 10.1152/ajpendo.00703.2010 1:CAS:528:DC%2BC3MXmsFCls7s%3D
18. JC Pickup 2004 Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes Diabetes Care 27 813 823 14988310 10.2337/diacare.27.3.813 (Pubitemid 38280558)